CalciMedica, Inc. (CALC) Key Metrics
CALC valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $7.1M
- Enterprise value
- $2.8M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- —
- Price / book
- 2.2
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 1.10
CALC key metrics, 2018–2025
Fiscal year ended December 31, 2025 · U.S. dollarsCALC returns How much profit the business earns on the capital it uses.
Return on assets−91.4 pts
−177.1%
2025 · hover or tap a bar for each year
20182025
Asset turnover
0.00
2025 · hover or tap a bar for each year
20182025
CALC financial health Debt, liquidity and how easily interest is covered.
Net debt+$15.4M
−$3.3M
2025 · hover or tap a bar for each year
20182025
Current ratio−33.0%
3.58
2025 · hover or tap a bar for each year
20182025
Interest coverage
-16.3
2025 · hover or tap a bar for each year
20182025
Debt / assets
0.71
2025 · hover or tap a bar for each year
20182025
CALC efficiency & capital use Working capital cycle and where the cash goes.
Days payables outstanding+1,781 days
12,533 days
2025 · hover or tap a bar for each year
20182025
CALC valuation history
Fiscal year-endToday8-year median
CALC returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CALC debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CALC cash returned to shareholders
DividendsBuybacksFree cash flow
CALC price vs earnings per share
Share price at year-endEPS (right axis)
CALC key metrics
2018–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||
| Market capitalization | — | $39.8M | — | — | — | — | — | — |
| Enterprise value | — | $21.1M | — | — | — | — | — | — |
| Price / book | — | 2.8 | — | — | — | — | — | — |
| Earnings yield | — | −34.4% | — | — | — | — | — | — |
| Free cash flow yield | — | −53.1% | — | — | — | — | — | — |
| Share price at fiscal year-end | $32.95 | $17.70 | $14.30 | $7.00 | $25.62 | $406.28 | — | — |
| Per share | ||||||||
| Revenue per share | — | $0.00 | — | — | — | — | — | — |
| Earnings per share | — | −$6.09 | — | — | — | — | — | — |
| Operating cash flow per share | — | −$9.40 | — | — | — | — | — | — |
| Free cash flow per share | — | −$9.41 | — | — | — | — | — | — |
| Cash per share | — | $8.30 | — | — | — | — | — | — |
| Book value per share | — | $6.41 | — | — | — | — | — | — |
| Tangible book value per share | — | $6.41 | — | — | — | — | — | — |
| Capex per share | — | $0.00 | — | — | — | — | — | — |
| Shares outstanding | — | 2.2M | — | — | — | — | — | — |
| Returns & profitability | ||||||||
| Return on equity (ROE) | — | −121.4% | — | — | −44.8% | −44.7% | −183.2% | −236.1% |
| Return on invested capital (ROIC) | — | — | — | — | — | — | −29.4% | −28.9% |
| Return on assets (ROA) | −177.1% | −85.7% | −442.3% | −21.6% | −41.9% | −38.7% | −126.7% | −159.3% |
| Return on tangible assets | −217.5% | −69.2% | −282.0% | −233.6% | −51.8% | −27.0% | −91.1% | −159.3% |
| Financial health | ||||||||
| Total debt | $9.7M | — | — | $5.4M | −$8,000 | −$27,000 | $131.4M | $78.8M |
| Cash & short-term investments | $13.0M | $18.7M | $11.2M | $1.3M | $63.7M | $95.0M | $36.0M | $12.8M |
| Net debt | −$3.3M | −$18.7M | −$11.2M | $4.0M | −$63.7M | −$95.1M | $95.4M | $66.0M |
| Debt / equity | — | — | — | — | −0.00 | −0.00 | 4.62 | 6.56 |
| Debt / assets | 0.71 | — | — | 1.60 | −0.00 | −0.00 | 3.23 | 4.42 |
| Current ratio | 3.58 | 5.34 | 2.88 | 0.36 | 16.53 | 14.18 | 2.96 | 2.32 |
| Quick ratio | 3.58 | 5.34 | 2.88 | 0.37 | 16.54 | 14.18 | 2.96 | 2.32 |
| Interest coverage | -16.3 | — | -346.1 | -107.5 | -285.3 | -208.6 | — | — |
| Working capital | $9.7M | $16.0M | $7.6M | −$3.0M | $63.0M | $92.2M | $24.0M | $7.7M |
| Invested capital | −$10.0M | −$4.3M | −$3.1M | −$5.2M | $1.3M | −$274,000 | $123.8M | $78.0M |
| Tangible asset value | −$6.6M | $14.4M | $8.2M | −$9.2M | $65.0M | $94.8M | $28.4M | $12.0M |
| Net current asset value | −$6.7M | $14.3M | $7.6M | −$10.9M | $63.0M | $92.2M | $24.0M | $7.7M |
| Graham net-net per share | — | $5.91 | — | — | — | — | — | — |
| Capital allocation | ||||||||
| Share buybacks (net) | — | — | — | — | — | — | $45,000 | — |
| Capex / depreciation | 0.61 | 0.14 | 1.34 | 0.08 | 0.94 | 2.59 | 2.00 | 8.35 |
| Efficiency | ||||||||
| Days of inventory on hand | — | — | — | -210.6 | -14.8 | — | — | — |
| Days payables outstanding | 12,533.0 | 10,751.8 | 13,483.0 | 11,908.1 | 1,069.0 | 3,303.0 | 4,311.9 | 5,262.3 |
| Receivables turnover | — | — | — | 0.00 | 0.00 | — | — | — |
| Payables turnover | 0.03 | 0.03 | 0.03 | 0.03 | 0.34 | 0.11 | 0.08 | 0.07 |
| Asset turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average receivables | — | — | — | $30,000 | $21,000 | — | — | — |
| Average payables | $1.6M | $1.7M | $2.1M | $1.7M | $1.5M | $3.6M | $3.6M | $2.5M |
| Average inventory | — | — | — | −$30,000 | −$21,000 | — | — | — |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from CALC's annual financial statements (latest annual report filed March 3, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
CALC valuation and financial ratios
It ended the year with $9.7 million of debt and $13.0 million in cash and short-term investments, a net cash position of $3.3 million.
See the CALC income statement, the CALC chart for price history, or the CALC stock overview for the latest quote and news.
CALC key metrics FAQ
How much debt does CalciMedica have?
CalciMedica had total debt of $9.7 million at the end of fiscal 2025 and more cash than debt.
What is CalciMedica's current ratio?
CalciMedica's current ratio was 3.58 at the end of fiscal 2025: current assets were 3.58 times current liabilities.